SCHEMBL8309933

SCHEMBL8309933

CC(=NOCCO)c1ccc(-c2ccc(C)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 7/20 0.48
PPARG P37231 7/20 0.48
S1PR1 P21453 5/20 0.47
LMNA P02545 2/20 0.45
PTBP1 P26599 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
CYP1A2 P05177 1/20 0.42
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
PPARD Q03181 1/20 0.35
NR1I2 O75469 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8309932 1.00 PPARA (0.48) PPARAPPARGS1PR1LMNAPTBP1
SCHEMBL17577932 0.95 PPARA (0.51) PPARAPPARGS1PR1LMNAPTBP1
SCHEMBL5610797 0.87 LMNA (0.56) PPARAPPARGS1PR1LMNAPTBP1
SCHEMBL5610798 0.87 LMNA (0.56) PPARAPPARGS1PR1LMNAPTBP1
SCHEMBL5609892 0.85 LMNA (0.65) PPARAPPARGS1PR1LMNAPTBP1
SCHEMBL5609899 0.85 LMNA (0.65) PPARAPPARGS1PR1LMNAPTBP1
SCHEMBL5609817 0.84 PPARG (0.50) PPARAPPARGS1PR1LMNAPTBP1
SCHEMBL5609820 0.84 PPARG (0.50) PPARAPPARGS1PR1LMNAPTBP1
SCHEMBL8443076 0.84 LMNA (0.42) PPARAPPARGS1PR1LMNAPTBP1
SCHEMBL8304869 0.81 PPARG (0.52) PPARAPPARGS1PR1LMNAPTBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed